Abstract
Background There is a well-established link between allergies and mental health. While both atopic and food allergies are associated with increased levels of depression and anxiety, it is unclear what the mechanism behind this relationship is. Several theories touch upon potential psychological mechanisms, but until now putative cognitive mechanisms of the link between mental health and allergies have been unexplored.
Methods We employed tablet-based deep cognitive phenotyping, and also recorded mental health, socio-economic status, and allergies in 533 children aged 7-9 years. We then employed mediation analyses to test whether cognitive mechanisms mediated the association between allergies and mental health.
Findings In line with previous research, we found children with allergies reported higher levels of anxiety and depression. Furthermore, compared to children without allergies, they showed faster processing speed, equal verbal short-term memory, and worse performance on tests of fluid reasoning, number sense, search organisation, and spatial short-term memory. We confirmed that these variables predicted allergic state using logistic regression. Most importantly, we found that cognition partially mediated the relationship between allergy and both anxiety and depression.
Interpretation Our results suggest that allergies bias children towards particular cognitive profiles, which in turn are risk factors for anxiety and depression. This supports the view that early cognitive interventions could reduce the number of allergic children that develops comorbid psychiatric conditions.
Funding This study was supported by grant TWCF0159 from the Templeton World Charity Foundation to DEA, and by the UK Medical Research Council.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by grant TWCF0159 from the Templeton World Charity Foundation to DEA, and by the UK Medical Research Council.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The authors will make a synthetic dataset available with the publication of this manuscript, as well as the analysis code via GitHub (https://github.com/esdalmaijer/). It will be constructed to match the properties of the original data (using R package synthpop), without the danger of potential deanonymisation of participants. The original data will be available from the corresponding author upon request, and upon signing an agreement to not publicly share it. This ensures that our analyses are reproducible, while maintaining the privacy of our participants.
